Home Page Complete Directory New Articles
  Natural Health Newsletters About Us Advertising

please visit our sponsor

**Free Natural Health Newsletters, Click Here**

  Article: Benfotiamine – A Light At The End Of The Long Term Care Tunnel? - by Zachary B. Malott  
  The long term care industry faces epidemic numbers of patients with diabetic complications over the coming years. The numbers of elderly patients are increasing due to the ageing of the baby boomer generation and will magnify a serious, chronic series of health complications never seen before in the long term care sector of our country as well as abroad. 

The Einstein College of Medicine in New York was the site of a research project involving a substance called benfotiamine that made headlines globally in 2003. The bottom line of that study was that a substance of the allithiamine group of the naturally occurring thiamine-derived compounds had positive effects on neuropathy, retinopathy and nephropathy and heart/circulatory problems in diabetics. 

Is Benfotiamine Only For The Treatment Of Diabetic Complications?

Other research has suggested that there are beneficial effects for diabetics and non-diabetics also. These benefits include sciatica, vascular health, general nerve health, lower blood pressure, grant cellular protection, anti-aging, fibromyalgia, prevention of lactic acidosis, and treatment for Alzheimer’s disease. Any condition that is the result of a thiamine deficiency will also respond quite well to benfotiamine. Of course, any bodily function that is improved by a therapeutic level of thiamine will certainly be enhanced by benfotiamine, since benfotiamine is perhaps the most effective form of thiamine. 

What Is Benfotiamine?

Benfotiamine, a derivative of thiamine (vitamin B1), was an invention of Japanese scientists and there is a U.S. patent on benfotiamine that was entered by the Japanese back in 1962. Japanese benfotiamine is considered the purest source of bulk benfotiamine and is favored by manufacturers globally who insist on the highest quality in their benfotiamine product.

Benfotiamine’s safety has been proven over 12 years of use in Europe for the treatment and prevention of diabetic complications among others. The patent on benfotiamine gave information that it is even less toxic than common vitamin B1 (thiamine hydrochloride usually). This patent was submitted in the United States in 1962 by the Japanese. 

Vitamin B1 has a long history of use as an oral supplement without reported adverse effects. Due to its therapeutic action in some frequently observed clinical syndromes, thiamine hydrochloride has been advised and used over a long period of time. There are no reports of adverse effects of oral thiamine, even at dosages of several hundred milligrams a day (SCOGS, 1978; DHEW, 1979; Marks, 1989).

Benfotiamine has shown to be very safe. To date, there have been no reports of any known, negative interactions with any medications. To the contrary, some medications actually can cause a thiamine deficiency in some people and benfotiamine could correct this serious situation.

Many researchers, medical experts, doctors, podiatrists and many medical publishers recommend benfotiamine for neuropathy, retinopathy nephropathy, heart/circulatory complications and B1 deficiencies. Any in depth study on the web will produce physicians, naturopaths, neurologists, optometrists, chiropractors, etc. who have very positive feelings about the effectiveness and potential of benfotiamine in terms of the research done to date on this important tool in the arsenal against neuropathy, retinopathy and beneficial for the heart and circulatory system. We have professional healthcare providers from all of these disciplines which shows the confidence the medical community has in the purity and bioavailability of our benfotiamine product.

Dr. David Williams, publisher of “Alternatives Newsletter”, wrote an in depth article concerning benfotiamine in his May, 2004 issue. This article is an eye opener in terms of how effective benfotiamine can be for many health conditions. If possible, it would be beneficial for any interested reader to take a look at this article. http://www.drdavidwilliams.com/

Dr Paul Chous is another medical professional who sees the merits of benfotiamine: 
"I suspect strongly that benfotiamine will mitigate (or, hopefully, prevent) DRT in humans, but the burden of proof has not yet been met. The case for symptomatic relief of neuropathy symptoms is, of course, more tangible." http://www.emuhealthproducts.com/drchous.html

In conclusion, the consensus for benfotiamine is very positive. The benefits are worth investigating. If you or anyone you know is a diabetic, the protection against diabetic complications makes benfotiamine a viable tool in their arsenal to protect themselves. If they already are experiencing complications such as neuropathy, retinopathy, and others they will benefit from possible decrease in the progression along with pain relief in terms of peripheral neuropathy and other neuropathies.


Zachary B. Malott, CEO of Brentwood Health International is available to discuss the research and merits of benfotiamine in terms of neuropathy and retinopathy. He can be contacted at:

505.354.0526 zachmalott@emuhealthproducts.com www.emuhealthproducts.com/benfotiamine.html 


Home Page | Complete Directory | Articles | Natural Health Newsletters | About Us | Advertising
© 1999-2003 Self Improvement Online, Inc. All rights reserved.